Newsletter Subject

Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDS

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Oct 27, 2023 08:06 PM

Email Preheader Text

Oncology Update Friday, October 27, 2023 ADVERTISEMENT Exclusives & Features Objective This study in

[MEDPAGE TODAY]( Oncology Update Friday, October 27, 2023 [Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDS]( [Novel Stool RNA Test More Sensitive for Detecting Colon Cancer Versus FIT]( [Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPC]( [New Options Challenge Standard Treatments in EGFR-Mutant NSCLC]( [ALK Inhibitor Outperforms Adjuvant Chemotherapy for Resected Lung Cancer]( ADVERTISEMENT Exclusives & Features [Infertility Definition Expanded to Be More Inclusive]( [Tinnitus Worsens for Vaccine Scientist Who Points to Onset After COVID Vax]( [AI Detects Diabetes; Problems With Predictive AI; Regulating AI in Health]( [Impact of sensitive circulating tumor DNA monitoring on CT scan intervals during postoperative colorectal cancer surveillance]( Objective This study investigated whether digital PCR (dPCR)-based circulating tumor DNA (ctDNA) monitoringcan allow longer intervals between computed tomography (CT) scans during postoperative... [READ MORE]( [Cancer disparities persisted even among clinical trial participants, study finds]( Getting Black and Hispanic people into clinical trials has been a mission for researchers. But a new study shows it isn’t enough to erase disparities. [READ MORE]( [Improving prediction of survival and progression in metastatic non-small cell lung cancer following immunotherapy through machine learning of circulating tumor DNA dynamics]( Objectives: To use modern machine-learning approaches to enhance and automate the feature extraction from the longitudinal ctDNA data and to improve the prediction of survival and disease... [READ MORE]( [Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study.]( BACKGROUND: Gastric cancer (GC) remains among the most common and most lethal cancers worldwide. Peritoneum is the most common site for distant dissemination. Standard treatment for GC peritoneal... [READ MORE]( [Association between hypertension grades and cancer mortality among Japanese men and women.]( PURPOSE: We aimed to examine the association between hypertension grades and the risk of total and site-specific cancer mortality among Japanese men and women.METHODS: In the Japan Collaborative... [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-10-27&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.